FI954105A0 - Novel 4-aminopyridines, their method of preparation and drugs containing these compounds - Google Patents
Novel 4-aminopyridines, their method of preparation and drugs containing these compoundsInfo
- Publication number
- FI954105A0 FI954105A0 FI954105A FI954105A FI954105A0 FI 954105 A0 FI954105 A0 FI 954105A0 FI 954105 A FI954105 A FI 954105A FI 954105 A FI954105 A FI 954105A FI 954105 A0 FI954105 A0 FI 954105A0
- Authority
- FI
- Finland
- Prior art keywords
- stands
- atom
- compounds
- hydrogen
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
New 4-aminopyridines have general formula (I), in which R<1> stands for the groups R<6>-SO-NR<7>, R<6>-SO2-NR<7>, R<6>-NR<7>-SO-, R<6>-NR<7>-SO2-, R<6>-SO-O-, R<6>-SO2-O-, R<6>-O-SO- or R<6>-O-SO2; R<2> stands for a hydrogen or halogen atom, a cyano, alkyl, alkoxy or halogen alkyl group; X stands for an oxygen atom, a sulphur atom or the NH group; R<3> and R<4> are the same or different and stand for hydrogen atoms or alkyl groups; R<5> stands for a hydrogen atom, an alkyl group or the aralkyl group; R<6> stands for an aliphatic or cyclic, if required substituted residue; R<7> stands for a hydrogen atom or an aliphatic or cyclic, if required substituted residue; Y stands for a linear or branched alkylene chain; R<8> and R<9> are the same or different and stand for hydrogen atoms, aralkyl, cycloalkyl or alkyl groups which may be substituted once or several times by halogen, hydroxy, alkoxy, alkylcarbonyloxy, amine or carboxy, or R<8> and R<9> form together with the N atom to which they are bound a saturated ring which may contain an additional oxygen, sulphur or nitrogen atom. Also disclosed are the hydrates, solvates and physiologically acceptable salts of these compounds, their optically active forms, racemates and diastereomer mixtures, a process for preparing said compounds, medicaments containing said compounds and the use of said compounds for producing medicaments.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4306506A DE4306506A1 (en) | 1993-03-03 | 1993-03-03 | Novel 4-alkylaminopyridines - processes for their preparation and medicaments containing these compounds |
DE19934312966 DE4312966A1 (en) | 1993-04-21 | 1993-04-21 | Novel 4-aminopyridines - process for their preparation and medicaments containing these compounds |
PCT/EP1994/000608 WO1994020467A1 (en) | 1993-03-03 | 1994-03-02 | New 4-aminopyridines, process for preparing the same and medicaments containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
FI954105A FI954105A (en) | 1995-09-01 |
FI954105A0 true FI954105A0 (en) | 1995-09-01 |
Family
ID=25923593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954105A FI954105A0 (en) | 1993-03-03 | 1995-09-01 | Novel 4-aminopyridines, their method of preparation and drugs containing these compounds |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0687253B1 (en) |
JP (1) | JPH08507503A (en) |
KR (1) | KR100252551B1 (en) |
CN (1) | CN1046710C (en) |
AT (1) | ATE174590T1 (en) |
AU (1) | AU682026B2 (en) |
CA (1) | CA2156729A1 (en) |
CZ (1) | CZ225495A3 (en) |
DE (1) | DE59407494D1 (en) |
DK (1) | DK0687253T3 (en) |
ES (1) | ES2127919T3 (en) |
FI (1) | FI954105A0 (en) |
GR (1) | GR3029691T3 (en) |
HU (1) | HUT72898A (en) |
IL (1) | IL108786A (en) |
NO (1) | NO953447D0 (en) |
NZ (1) | NZ262725A (en) |
PL (1) | PL176455B1 (en) |
RU (1) | RU2126388C1 (en) |
SK (1) | SK108295A3 (en) |
TW (1) | TW257757B (en) |
WO (1) | WO1994020467A1 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4430755A1 (en) * | 1994-08-30 | 1996-03-07 | Boehringer Mannheim Gmbh | New phosphine oxides, processes for their preparation and medicaments containing these compounds |
IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
US5792769A (en) * | 1995-09-29 | 1998-08-11 | 3-Dimensional Pharmaceuticals, Inc. | Guanidino protease inhibitors |
GB9525620D0 (en) | 1995-12-15 | 1996-02-14 | Glaxo Group Ltd | Chemical compounds |
IL124883A0 (en) * | 1995-12-29 | 1999-01-26 | Dimensional Pharm Inc | Amidino protease inhibitors and pharmaceutical compositions containing the same |
GB9602166D0 (en) | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
US6313127B1 (en) | 1996-02-02 | 2001-11-06 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
SE9602646D0 (en) * | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically useful compounds |
CZ45699A3 (en) * | 1996-08-14 | 1999-05-12 | Zeneca Limited | Substituted pyrimidine derivatives, process of their preparation and pharmaceutical composition containing thereof |
WO1998010763A1 (en) * | 1996-09-13 | 1998-03-19 | Merck & Co., Inc. | Thrombin inhibitors |
GB9821483D0 (en) | 1998-10-03 | 1998-11-25 | Glaxo Group Ltd | Chemical compounds |
UA56197C2 (en) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Heterocyclic derivatives |
TW499412B (en) | 1996-11-26 | 2002-08-21 | Dimensional Pharm Inc | Aminoguanidines and alkoxyguanidines as protease inhibitors |
WO1998024760A1 (en) * | 1996-12-03 | 1998-06-11 | Graybill Todd L | Aminobenzenedicarboxylic acid-based combinatorial libraries |
US6440972B1 (en) | 1997-02-13 | 2002-08-27 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
DE69815509T2 (en) | 1997-02-13 | 2004-05-13 | Astrazeneca Ab | HETEROCYCLIC COMPOUNDS THAT APPLY AS OXIDO-SQUALEN-CYCLASE INHIBITORS |
GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
JP4327915B2 (en) * | 1998-03-30 | 2009-09-09 | 株式会社デ・ウエスタン・セラピテクス研究所 | Sulfonamide derivatives |
CA2345577A1 (en) | 1998-10-06 | 2000-04-13 | Mari Itoh | 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
AR023510A1 (en) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | A TEAM OF PARTS, PHARMACEUTICAL FORMULATION AND USE OF A THROMBIN INHIBITOR. |
WO2002012207A1 (en) | 2000-08-04 | 2002-02-14 | 3-Dimensional Pharmaceuticals, Inc. | Cyclic oxyguanidine protease inhibitors |
US20050043536A1 (en) * | 2001-05-07 | 2005-02-24 | Dashyant Dhanak | Sulfonamides |
WO2002089785A1 (en) * | 2001-05-07 | 2002-11-14 | Smithkline Beecham Corporation | Sulfonamides |
CN1678314A (en) * | 2002-08-27 | 2005-10-05 | 默克专利有限公司 | Glycinamide derivatives as raf-kinase inhibitors |
WO2004026823A1 (en) | 2002-09-20 | 2004-04-01 | Pfizer Products Inc. | Amide and sulfonamide ligands for the estrogen receptor |
KR100847976B1 (en) | 2003-11-05 | 2008-07-22 | 에프. 호프만-라 로슈 아게 | Phenyl derivatives as ppar agonists |
WO2008104994A2 (en) * | 2007-02-28 | 2008-09-04 | Advinus Therapeutics Private Limited | 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
RU2354647C2 (en) * | 2007-06-28 | 2009-05-10 | Общество С Ограниченной Ответственностью "Бионика" | New compounds with thrombin inhibiting function, and based pharmaceutical compositions |
RU2353619C2 (en) * | 2007-06-28 | 2009-04-27 | Общество С Ограниченной Ответственностью "Бионика" | Novel compounds possessing anticoagulant function, based on them pharmaceutical compositions for treatment of thrombotic conditions and plasma-substituting solution for correction of hypercoagulation disorders in hemodilution |
GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
US8265575B2 (en) * | 2009-06-16 | 2012-09-11 | Mediatek Inc. | Methods for handling a transmitting process and communication apparatuses utilizing the same |
US8207639B2 (en) | 2009-10-23 | 2012-06-26 | Sunonwealth Electric Machine Industry Co., Ltd. | Motor and heating dissipating fan including motor having an annular balancing member |
RU2685261C1 (en) * | 2018-04-05 | 2019-04-17 | Общество с ограниченной ответственностью "ФК ЛАБОРАТОРИЗ" | 4-amino-1-{2-[3-methyl-5-(benzenesulfonyloxy]phenoxy]ethyl}-pyridium chloride substance, having the biologically active agent properties, influencing the mammals blood coagulability naturally running processes, anticoagulant on its basis and its obtaining method by chemical synthesis |
CN109172573B (en) * | 2018-09-12 | 2021-01-26 | 黑龙江中桂制药有限公司 | Oral antithrombotic drug and application thereof |
CN110669337B (en) * | 2019-07-08 | 2020-09-25 | 中国科学院长春应用化学研究所 | Aromatic diamine monomer and preparation method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8819307D0 (en) * | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Antiarrhythmic agents |
JPH0256465A (en) * | 1988-08-22 | 1990-02-26 | Hamari Yakuhin Kogyo Kk | Acetamide compound |
EP0610432A1 (en) * | 1991-10-31 | 1994-08-17 | Smithkline Beecham Corporation | C8-cyclic peptidomimetics as fibrinogen antagonists |
AU2915892A (en) * | 1991-11-14 | 1993-06-15 | Glaxo Group Limited | Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
DE4212304A1 (en) * | 1992-04-13 | 1993-10-14 | Cassella Ag | Aspartic acid derivatives, their preparation and use |
-
1994
- 1994-02-22 TW TW083101504A patent/TW257757B/zh active
- 1994-02-28 IL IL10878694A patent/IL108786A/en not_active IP Right Cessation
- 1994-03-02 WO PCT/EP1994/000608 patent/WO1994020467A1/en not_active Application Discontinuation
- 1994-03-02 DE DE59407494T patent/DE59407494D1/en not_active Expired - Fee Related
- 1994-03-02 AT AT94909909T patent/ATE174590T1/en not_active IP Right Cessation
- 1994-03-02 HU HU9502568A patent/HUT72898A/en unknown
- 1994-03-02 ES ES94909909T patent/ES2127919T3/en not_active Expired - Lifetime
- 1994-03-02 SK SK1082-95A patent/SK108295A3/en unknown
- 1994-03-02 EP EP94909909A patent/EP0687253B1/en not_active Expired - Lifetime
- 1994-03-02 CZ CZ952254A patent/CZ225495A3/en unknown
- 1994-03-02 PL PL94310520A patent/PL176455B1/en unknown
- 1994-03-02 CA CA002156729A patent/CA2156729A1/en not_active Abandoned
- 1994-03-02 DK DK94909909T patent/DK0687253T3/en active
- 1994-03-02 RU RU95122612A patent/RU2126388C1/en active
- 1994-03-02 AU AU62574/94A patent/AU682026B2/en not_active Ceased
- 1994-03-02 JP JP6519556A patent/JPH08507503A/en active Pending
- 1994-03-02 KR KR1019950703694A patent/KR100252551B1/en not_active IP Right Cessation
- 1994-03-02 CN CN94191554A patent/CN1046710C/en not_active Expired - Fee Related
- 1994-03-02 NZ NZ262725A patent/NZ262725A/en unknown
-
1995
- 1995-09-01 FI FI954105A patent/FI954105A0/en unknown
- 1995-09-01 NO NO953447A patent/NO953447D0/en unknown
-
1999
- 1999-03-16 GR GR990400775T patent/GR3029691T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK0687253T3 (en) | 1999-08-23 |
TW257757B (en) | 1995-09-21 |
CN1119858A (en) | 1996-04-03 |
KR100252551B1 (en) | 2000-05-01 |
CA2156729A1 (en) | 1994-09-15 |
NO953447L (en) | 1995-09-01 |
JPH08507503A (en) | 1996-08-13 |
AU6257494A (en) | 1994-09-26 |
HUT72898A (en) | 1996-06-28 |
KR960701019A (en) | 1996-02-24 |
NZ262725A (en) | 1997-05-26 |
EP0687253A1 (en) | 1995-12-20 |
PL310520A1 (en) | 1995-12-27 |
IL108786A (en) | 1999-04-11 |
ES2127919T3 (en) | 1999-05-01 |
EP0687253B1 (en) | 1998-12-16 |
SK108295A3 (en) | 1996-06-05 |
HU9502568D0 (en) | 1995-11-28 |
GR3029691T3 (en) | 1999-06-30 |
PL176455B1 (en) | 1999-05-31 |
CN1046710C (en) | 1999-11-24 |
FI954105A (en) | 1995-09-01 |
IL108786A0 (en) | 1994-06-24 |
DE59407494D1 (en) | 1999-01-28 |
NO953447D0 (en) | 1995-09-01 |
CZ225495A3 (en) | 1996-01-17 |
AU682026B2 (en) | 1997-09-18 |
ATE174590T1 (en) | 1999-01-15 |
RU2126388C1 (en) | 1999-02-20 |
WO1994020467A1 (en) | 1994-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI954105A0 (en) | Novel 4-aminopyridines, their method of preparation and drugs containing these compounds | |
ZA919181B (en) | Oxazolopyridine derivatives,processes for preparing these and pharmaceutical compositions containing them | |
DE68900180D1 (en) | AMINE, THEIR USE AND PRODUCTION. | |
NO951775D0 (en) | New 3,3-diphenylpropylamines, their use and preparation | |
MX9707053A (en) | Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds. | |
DE3777852D1 (en) | DEKAHYDROCHINOLIN DERIVATIVES, METHOD FOR THEIR PRODUCTION, INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, THEIR USE AS MEDICINAL PRODUCTS AND PREPARATIONS THEREOF. | |
IL102093A0 (en) | 1-methylcarbapenem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
DK0488513T3 (en) | Use of dioxabicyclo (3.3.0) octane derivatives to prepare a drug for inhibiting cholesterol metabolism | |
SE7501365L (en) | ||
ATE66913T1 (en) | AMIDE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND COMPOSITION FOR ACTIVATING GASTROMOTOR FUNCTIONS. | |
HUP0004588A2 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments and pharmaceutical compositions containing them | |
ATE116647T1 (en) | THIOPHENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
SE8804688D0 (en) | SUBSTITUTED GOVERNMENT DERIVATIVES | |
ZA918991B (en) | Imidazole compounds,process for the preparation thereof and pharmaceutical compositions containing them | |
UA50722C2 (en) | Nitrobenzamides, method for their production (variants), pharmaceutical composition | |
ATE231136T1 (en) | THIAZOLIDINEDIONE DERIVATIVES HAVING ANTIDIABETIC, HYPOLIPIDEMIC AND ANTIHYPERTENSIVE PROPERTIES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
DE68905363D1 (en) | HETEROTETRACYCLIC LACTAM DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS THEREOF. | |
ZA899321B (en) | Indole derivatives,process for preparing them and pharmaceutical compositions containing them | |
DE3860117D1 (en) | 2,3-DIHYDRO-3-PHENYL-BENZOFURAN-2-ON-ACETAMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Name/ company changed in application |
Owner name: ROCHE DIAGNOSTICS GMBH |